These case reports also show mixed reduction in ferritin, IL-2, IL-6, IL-8, IL-10, TNF-α after administration of emapalumab, suggesting some differences in the overall inflammatory cascade in CRS induced by PSCA vs CD19-targeted CAR-T. This evidence concerns the gene CXCL8 and congenital rubella syndrome.